This is the
talk page for discussing improvements to the
Johnson & Johnson article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google ( books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
This article is written in American English, which has its own spelling conventions (color, defense, traveled) and some terms that are used in it may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus. |
This
level-5 vital article is rated B-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Text and/or other creative content from this version of Johnson & Johnson COVID-19 vaccine was copied or moved into Johnson & Johnson with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
Text and/or other creative content from this version of Johnson & Johnson was copied or moved into 2010 Johnson & Johnson children's product recall with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
The
Wikimedia Foundation's
Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see
WP:PAID. For advice about reviewing paid contributions, see
WP:COIRESPONSE.
|
Archives ( Index) |
This page is archived by
ClueBot III.
|
The article has some outdated content; below are the suggested edits. The proposed improvements can help reduce the size of the article. First, there are some simple edits, such as updating the Board of Directors and Executive Committee. Done — Grand'mere Eugene ( talk) 21:24, 23 June 2023 (UTC)
June 2023 Edits
|
---|
The Headquarters and the New Brunswick gentrification section is duplicate content from the Johnson and Johnson Plaza article, and the sentences are poorly sourced. The sourced content in the section fits into the History section, and it would remove the duplicated content. Take a look at the suggestion below. 1. Please Update the Board of Directors and Executive Committee The current members of the board of directors of Johnson & Johnson for 2023 are Joaquin Duato, Darius Adamczyk, Mary C. Beckerle, D. Scott Davis, Jennifer A. Doudna, Marillyn A. Hewson, Paula A. Johnson, Hubert Joly, Mark B. McClellan, Anne M. Mulcahy, Mark A. Weinberger, and Nadja Y. West. [1] The current members of the Executive Committee of Johnson & Johnson are Joaquin Duato, Vanessa Broadhurst, Peter Fasolo, Liz Forminard, William N. Hait, Ashley McEvoy, John C. Reed, James Swanson, Jennifer Taubert, Kathy Wengel, and Joseph J. Wolk. [2] 2. Remove the two graphs from Finance section. The graphs are not working due to technical issues. 3. Remove the Headquarters and the New Brunswick gentrification section, then add suggested sentences to the history section. Existing Content (Headquarters and the New Brunswick gentrification) The company has historically been located on the Delaware and Raritan Canal in New Brunswick. The company considered moving its Headquarters out of New Brunswick in the 1960s but decided to stay in the town after city officials promised to revitalize downtown New Brunswick by demolishing old buildings and constructing new ones. While New Brunswick lost many historic structures, including the early home of Rutgers University, and most of its historic commercial waterfront to the redevelopment effort, the gentrification did attract people back to New Brunswick. Johnson & Johnson hired Henry N. Cobb from Pei Cobb Freed & Partners to design its new Headquarters. Johnson and Johnson Plaza, in a park across the railroad tracks from the older portion of the Headquarters, is one of tallest buildings in New Brunswick.[ citation needed] The stretch of Delaware and Raritan canal by the company's Headquarters was replaced by a stretch of Route 18 in the late 1970s, after a lengthy dispute. In 2002, the company released its plan of setting up Asia-Pacific information technology headquarters in New South Wales within five years. New Content (Move section to the History section) Move to 1886: Founding of Johnson & Johnson as sentence three Johnson & Johnson opened its first factory building in the old Janeway and Carpenter factory on Neilson Street in New Brunswick, New Jersey. [3] Move to 1944-1999: Acquisitions and international expansion as paragraph eight. In the 1970s, Johnson & Johnson hired Henry N. Cobb from Pei Cobb Freed & Partners to design its new Headquarters. [4] The firm designed Johnson & Johnson Plaza across the railroad tracks from the older section of the Johnson & Johnson campus. [5] 4. Question: Should we remove the tree diagram from the COVID section? It doesn't really make sense in that section, it needs to be updated, and it's adding a lot of unnecessary bytes to the article. Thoughts?
References
Chefmikesf ( talk) 21:01, 22 June 2023 (UTC) |
Hi KAISEAN W. and Grand'mere Eugene, There are some significant changes to the company with the split-off and exchange offer. I'm currently working on a proposed sandbox to address all the changes. Would you be open to reviewing the changes later in the week? Thanks in advance--- Chefmikesf ( talk) 22:07, 22 August 2023 (UTC)
Done — Grand'mere Eugene ( talk) 09:57, 30 August 2023 (UTC)
JNJ Split-off Content
|
---|
References
|
Hi @ Grand'mere Eugene I noticed the last section of the History section got bit unwieldy. Any thoughts on the suggestion?
JNJ History
|
---|
1. Reason and Request: Patent on tuberculosis-treating drug, bedaquiline History subsection lacks secondary sources. Suggest removing most of the content and the subsection. Once removed, add the content below to the 2000–present subsection in chronological order after the Kenvue content. 2000–present...9.5% of the outstanding shares of Kenvue common stock. Johnson & Johnson holds a patent on the tuberculosis-treating drug bedaquiline, with secondary patents in at least 25 out of 43 countries with a high burden of tuberculosis blocking affordable generic versions of the drug, preventing millions of people from accessing the life-saving treatment. [1] [2] Though the patent was set to expire in many countries in 2023, Johnson & Johnson applied to extend the patent. On July 13, 2023, Stop TB Partnership announced that after negotiations with Johnson & Johnson, they had been granted licenses to produce generic versions of the drug. [3]
References
Done Good catch. — Grand'mere Eugene ( talk) 01:06, 5 December 2023 (UTC)
|
Handle-o-Meter isn't notable in itself, but a merge/redirect here could be helpful to readers. Boleyn ( talk) 15:51, 17 November 2023 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 22 January 2024 and 29 April 2024. Further details are available on the course page. Student editor(s): Frog231 ( article contribs). Peer reviewers: LLonergan802.
— Assignment last updated by TotalSolarEclipse ( talk) 17:03, 24 February 2024 (UTC)
This is the
talk page for discussing improvements to the
Johnson & Johnson article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google ( books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
This article is written in American English, which has its own spelling conventions (color, defense, traveled) and some terms that are used in it may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus. |
This
level-5 vital article is rated B-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Text and/or other creative content from this version of Johnson & Johnson COVID-19 vaccine was copied or moved into Johnson & Johnson with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
Text and/or other creative content from this version of Johnson & Johnson was copied or moved into 2010 Johnson & Johnson children's product recall with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
The
Wikimedia Foundation's
Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see
WP:PAID. For advice about reviewing paid contributions, see
WP:COIRESPONSE.
|
Archives ( Index) |
This page is archived by
ClueBot III.
|
The article has some outdated content; below are the suggested edits. The proposed improvements can help reduce the size of the article. First, there are some simple edits, such as updating the Board of Directors and Executive Committee. Done — Grand'mere Eugene ( talk) 21:24, 23 June 2023 (UTC)
June 2023 Edits
|
---|
The Headquarters and the New Brunswick gentrification section is duplicate content from the Johnson and Johnson Plaza article, and the sentences are poorly sourced. The sourced content in the section fits into the History section, and it would remove the duplicated content. Take a look at the suggestion below. 1. Please Update the Board of Directors and Executive Committee The current members of the board of directors of Johnson & Johnson for 2023 are Joaquin Duato, Darius Adamczyk, Mary C. Beckerle, D. Scott Davis, Jennifer A. Doudna, Marillyn A. Hewson, Paula A. Johnson, Hubert Joly, Mark B. McClellan, Anne M. Mulcahy, Mark A. Weinberger, and Nadja Y. West. [1] The current members of the Executive Committee of Johnson & Johnson are Joaquin Duato, Vanessa Broadhurst, Peter Fasolo, Liz Forminard, William N. Hait, Ashley McEvoy, John C. Reed, James Swanson, Jennifer Taubert, Kathy Wengel, and Joseph J. Wolk. [2] 2. Remove the two graphs from Finance section. The graphs are not working due to technical issues. 3. Remove the Headquarters and the New Brunswick gentrification section, then add suggested sentences to the history section. Existing Content (Headquarters and the New Brunswick gentrification) The company has historically been located on the Delaware and Raritan Canal in New Brunswick. The company considered moving its Headquarters out of New Brunswick in the 1960s but decided to stay in the town after city officials promised to revitalize downtown New Brunswick by demolishing old buildings and constructing new ones. While New Brunswick lost many historic structures, including the early home of Rutgers University, and most of its historic commercial waterfront to the redevelopment effort, the gentrification did attract people back to New Brunswick. Johnson & Johnson hired Henry N. Cobb from Pei Cobb Freed & Partners to design its new Headquarters. Johnson and Johnson Plaza, in a park across the railroad tracks from the older portion of the Headquarters, is one of tallest buildings in New Brunswick.[ citation needed] The stretch of Delaware and Raritan canal by the company's Headquarters was replaced by a stretch of Route 18 in the late 1970s, after a lengthy dispute. In 2002, the company released its plan of setting up Asia-Pacific information technology headquarters in New South Wales within five years. New Content (Move section to the History section) Move to 1886: Founding of Johnson & Johnson as sentence three Johnson & Johnson opened its first factory building in the old Janeway and Carpenter factory on Neilson Street in New Brunswick, New Jersey. [3] Move to 1944-1999: Acquisitions and international expansion as paragraph eight. In the 1970s, Johnson & Johnson hired Henry N. Cobb from Pei Cobb Freed & Partners to design its new Headquarters. [4] The firm designed Johnson & Johnson Plaza across the railroad tracks from the older section of the Johnson & Johnson campus. [5] 4. Question: Should we remove the tree diagram from the COVID section? It doesn't really make sense in that section, it needs to be updated, and it's adding a lot of unnecessary bytes to the article. Thoughts?
References
Chefmikesf ( talk) 21:01, 22 June 2023 (UTC) |
Hi KAISEAN W. and Grand'mere Eugene, There are some significant changes to the company with the split-off and exchange offer. I'm currently working on a proposed sandbox to address all the changes. Would you be open to reviewing the changes later in the week? Thanks in advance--- Chefmikesf ( talk) 22:07, 22 August 2023 (UTC)
Done — Grand'mere Eugene ( talk) 09:57, 30 August 2023 (UTC)
JNJ Split-off Content
|
---|
References
|
Hi @ Grand'mere Eugene I noticed the last section of the History section got bit unwieldy. Any thoughts on the suggestion?
JNJ History
|
---|
1. Reason and Request: Patent on tuberculosis-treating drug, bedaquiline History subsection lacks secondary sources. Suggest removing most of the content and the subsection. Once removed, add the content below to the 2000–present subsection in chronological order after the Kenvue content. 2000–present...9.5% of the outstanding shares of Kenvue common stock. Johnson & Johnson holds a patent on the tuberculosis-treating drug bedaquiline, with secondary patents in at least 25 out of 43 countries with a high burden of tuberculosis blocking affordable generic versions of the drug, preventing millions of people from accessing the life-saving treatment. [1] [2] Though the patent was set to expire in many countries in 2023, Johnson & Johnson applied to extend the patent. On July 13, 2023, Stop TB Partnership announced that after negotiations with Johnson & Johnson, they had been granted licenses to produce generic versions of the drug. [3]
References
Done Good catch. — Grand'mere Eugene ( talk) 01:06, 5 December 2023 (UTC)
|
Handle-o-Meter isn't notable in itself, but a merge/redirect here could be helpful to readers. Boleyn ( talk) 15:51, 17 November 2023 (UTC)
This article was the subject of a Wiki Education Foundation-supported course assignment, between 22 January 2024 and 29 April 2024. Further details are available on the course page. Student editor(s): Frog231 ( article contribs). Peer reviewers: LLonergan802.
— Assignment last updated by TotalSolarEclipse ( talk) 17:03, 24 February 2024 (UTC)